[ORGANIZATION]
Contract Development and Manufacturing Organisation (CDMO)
Featured in 1 tracked story · first seen
Situations
Piramal Pharma business expansion and growth
2 clusters · 7 sources · last updated
Latest: Piramal Pharma acquires controlling stake in Yapan Bio
Piramal Pharma Limited reported strong financial performance for the first quarter of fiscal year 2027, noting a 17% increase in revenue to ₹2,270 crore and a 72% rise in EBITDA to ₹285 crore. Chairperson Nandini Piramal